Isopimpinellin inhibits Nos2/Ptgs2 inflammatory signaling to suppress macrophage M1 polarization and ameliorate DSS-induced colitis

Introduction Disordered M1 skewed macrophage polarization and subsequent intestinal mucosal barrier failure are central pathogenic hallmarks of acute inflammatory bowel disease (IBD). Excessive pro inflammatory activation of lamina propria macrophages drives cytokine bursts and nitrosative stress, which collectively disrupt epithelial integrity and accelerate disease progression. Methods We evaluated the therapeutic efficacy of the natural furanocoumarin isopimpinellin (ISOP) using a dextran sulfate sodium (DSS)-induced colitis mouse model compared to a vehicle solvent control group, alongside in vitro primary bone marrow-derived macrophages (BMDMs). The direct pharmacological targets of ISOP were elucidated through an integrated approach utilizing quantitative proteomics, network analysis, molecular docking, and cellular thermal shift assays (CETSA). Pharmacological causality was validated via in vitro and in vivo rescue experiments using a nitric oxide (NO) donor and exogenous prostaglandin E2 (PGE2). Results and Discussion In vivo , ISOP mitigated colitic manifestations, reduced intestinal epithelial hyper permeability, preserved goblet cell associated mucin layers, restored tight junction ultrastructure and alleviated epithelial mitochondrial damage. ISOP further reshaped the colonic immune microenvironment by restraining pathological M1 macrophage infiltration, rebalancing the intestinal M1/M2 macrophage ratio, suppressing pro inflammatory cytokine release and up regulating tissue repair related anti inflammatory mediators. Integrated strategies combining quantitative proteomics, molecular docking and CETSA were adopted to screen and characterize the direct molecular targets of ISOP, while NO donor and PGE₂ rescue assays further verified its pharmacological mechanism of action. Mechanistically, ISOP negatively regulates the Nos2/Ptgs2-associated inflammatory signaling pathway by reducing iNOS (Nos2) and COX-2 (Ptgs2) protein levels, thereby suppressing M1 macrophage-derived inflammatory and nitrosative stress. Consistently, simultaneous exogenous supplementation of NO and PGE2 largely abolished ISOP derived anti inflammatory and mucosal protective effects both in vitro and in vivo. Collectively, these findings indicate that ISOP ameliorates acute colitis by restoring intestinal mucosal barrier function and normalizing macrophage immune homeostasis, supporting ISOP as a promising natural bioactive candidate for the targeted management of acute IBD.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.2019565
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Isopimpinellin inhibits Nos2/Ptgs2 inflammatory signaling to suppress macrophage M1 polarization and ameliorate DSS-induced colitis

Zhijun Geng, Yujie He, Ju Huang, Yingying Zhang et al.
Frontiers in Immunology
Inflammatory Bowel Disease
article

Isopimpinellin inhibits Nos2/Ptgs2 inflammatory signaling to suppress macrophage M1 polarization and ameliorate DSS-induced colitis

Zhijun Geng, Yujie He, Ju Huang, Yingying Zhang, Yu Zhang, Qi Ding, Xihao Wang, Jinlin Cao, Qingqing Li, Lu Han, Longtao Zhang, Weili Yang, Junli Zhou, Jing Li, Jiayi Sun
article en

Abstract

Introduction Disordered M1 skewed macrophage polarization and subsequent intestinal mucosal barrier failure are central pathogenic hallmarks of acute inflammatory bowel disease (IBD). Excessive pro inflammatory activation of lamina propria macrophages drives cytokine bursts and nitrosative stress, which collectively disrupt epithelial integrity and accelerate disease progression. Methods We evaluated the therapeutic efficacy of the natural furanocoumarin isopimpinellin (ISOP) using a dextran sulfate sodium (DSS)-induced colitis mouse model compared to a vehicle solvent control group, alongside in vitro primary bone marrow-derived macrophages (BMDMs). The direct pharmacological targets of ISOP were elucidated through an integrated approach utilizing quantitative proteomics, network analysis, molecular docking, and cellular thermal shift assays (CETSA). Pharmacological causality was validated via in vitro and in vivo rescue experiments using a nitric oxide (NO) donor and exogenous prostaglandin E2 (PGE2). Results and Discussion In vivo , ISOP mitigated colitic manifestations, reduced intestinal epithelial hyper permeability, preserved goblet cell associated mucin layers, restored tight junction ultrastructure and alleviated epithelial mitochondrial damage. ISOP further reshaped the colonic immune microenvironment by restraining pathological M1 macrophage infiltration, rebalancing the intestinal M1/M2 macrophage ratio, suppressing pro inflammatory cytokine release and up regulating tissue repair related anti inflammatory mediators. Integrated strategies combining quantitative proteomics, molecular docking and CETSA were adopted to screen and characterize the direct molecular targets of ISOP, while NO donor and PGE₂ rescue assays further verified its pharmacological mechanism of action. Mechanistically, ISOP negatively regulates the Nos2/Ptgs2-associated inflammatory signaling pathway by reducing iNOS (Nos2) and COX-2 (Ptgs2) protein levels, thereby suppressing M1 macrophage-derived inflammatory and nitrosative stress. Consistently, simultaneous exogenous supplementation of NO and PGE2 largely abolished ISOP derived anti inflammatory and mucosal protective effects both in vitro and in vivo. Collectively, these findings indicate that ISOP ameliorates acute colitis by restoring intestinal mucosal barrier function and normalizing macrophage immune homeostasis, supporting ISOP as a promising natural bioactive candidate for the targeted management of acute IBD.

Frontiers in ImmunologyVol. 17
Bengbu Medical College (CN), First Affiliated Hospital of Bengbu Medical College (CN)
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon